[go: up one dir, main page]

SK10982003A3 - Nové použitie - Google Patents

Nové použitie Download PDF

Info

Publication number
SK10982003A3
SK10982003A3 SK1098-2003A SK10982003A SK10982003A3 SK 10982003 A3 SK10982003 A3 SK 10982003A3 SK 10982003 A SK10982003 A SK 10982003A SK 10982003 A3 SK10982003 A3 SK 10982003A3
Authority
SK
Slovakia
Prior art keywords
alkyl
alkoxy
group
halogen
compound
Prior art date
Application number
SK1098-2003A
Other languages
English (en)
Slovak (sk)
Inventor
Arne Eek
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0100798A external-priority patent/SE0100798D0/xx
Priority claimed from SE0103291A external-priority patent/SE0103291D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of SK10982003A3 publication Critical patent/SK10982003A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK1098-2003A 2001-03-08 2002-03-05 Nové použitie SK10982003A3 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0100798A SE0100798D0 (sv) 2001-03-08 2001-03-08 New use
SE0103291A SE0103291D0 (sv) 2001-10-03 2001-10-03 New use
PCT/SE2002/000375 WO2002069968A1 (en) 2001-03-08 2002-03-05 New use

Publications (1)

Publication Number Publication Date
SK10982003A3 true SK10982003A3 (sk) 2004-02-03

Family

ID=26655407

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1098-2003A SK10982003A3 (sk) 2001-03-08 2002-03-05 Nové použitie

Country Status (15)

Country Link
US (2) US20040082605A1 (ja)
EP (1) EP1370261A2 (ja)
JP (1) JP2004520422A (ja)
KR (1) KR100904599B1 (ja)
CN (1) CN1496259A (ja)
BG (1) BG108144A (ja)
BR (1) BR0207762A (ja)
CA (1) CA2440100A1 (ja)
CZ (1) CZ20032398A3 (ja)
EE (1) EE05234B1 (ja)
IL (1) IL157461A0 (ja)
MX (1) MXPA03007888A (ja)
NO (1) NO20033919D0 (ja)
SK (1) SK10982003A3 (ja)
WO (1) WO2002069968A1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
AU2003254282A1 (en) * 2002-08-01 2004-02-23 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
KR20050072090A (ko) * 2002-09-19 2005-07-08 쉐링 코포레이션 사이클린 의존성 키나제 억제제로서의 피라졸로피리딘
TWI351405B (en) * 2002-09-19 2011-11-01 Schering Corp Novel imidazopyridines as cyclin dependent kinase
CN1747731A (zh) * 2003-02-17 2006-03-15 艾塔那法玛公司 含有咪唑并吡啶的组合和其在治疗胃肠炎性病症中的用途
JPWO2011102460A1 (ja) * 2010-02-19 2013-06-17 学校法人関西医科大学 胃潰瘍の予防又は治療剤、経口投与薬、及び胃潰瘍の予防又は治療剤の製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT290523B (de) * 1962-01-05 1971-06-11 Merck & Co Inc Verfahren zur Herstellung neuer α-(3-Indolyl)-carbonsäuren
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
DE3269604D1 (en) * 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
DE3922387A1 (de) * 1989-07-07 1991-01-17 Kali Chemie Pharma Gmbh N-benzyl-n-((1s,5s)-6,6-dimethylbicyclo/3.1.1/hept-2-ylaethoxy-aethyl)-morpholinium-salze enthaltende gastroprotektiv wirksame pharmazeutische zubereitungen
NZ235877A (en) * 1989-11-02 1992-09-25 Mcneil Ppc Inc Composition comprising acetaminophen or nsaid and an h 1 or h 2 receptor blocker and/or proton pump inhibitor for treating overindulgence
KR920002148A (ko) * 1990-07-03 1992-02-28 안드레아 엘. 콜비 비스테로이드계 소염제에 의해 유발된 위장 증상을 완화시키기 위한 약제 조성물 및 이를 완화시키는 방법
ES2130152T3 (es) * 1991-12-06 1999-07-01 Glaxo Group Ltd Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
WO1998042707A1 (en) * 1997-03-24 1998-10-01 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahydropyrido compounds
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
HUP0102990A3 (en) * 1998-09-23 2002-09-30 Altana Pharma Ag Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof
DE60002855T2 (de) * 1999-04-17 2004-05-06 Altana Pharma Ag Haloalkoxy-imidazonaphthyridine

Also Published As

Publication number Publication date
NO20033919L (no) 2003-09-04
US20040082605A1 (en) 2004-04-29
KR100904599B1 (ko) 2009-06-25
BR0207762A (pt) 2004-06-01
MXPA03007888A (es) 2003-12-04
EP1370261A2 (en) 2003-12-17
IL157461A0 (en) 2004-03-28
EE200300434A (et) 2003-12-15
US20090170854A1 (en) 2009-07-02
JP2004520422A (ja) 2004-07-08
EE05234B1 (et) 2009-12-15
NO20033919D0 (no) 2003-09-04
CZ20032398A3 (cs) 2004-02-18
KR20040007461A (ko) 2004-01-24
WO2002069968A8 (en) 2003-04-17
WO2002069968A1 (en) 2002-09-12
CA2440100A1 (en) 2002-09-12
CN1496259A (zh) 2004-05-12
BG108144A (en) 2004-09-30

Similar Documents

Publication Publication Date Title
AU2014372166B2 (en) Pharmaceutical combinations
RU2325913C2 (ru) Применение золедроновой кислоты, ее солей, гидратов и способ антиноцицептивного или антиаллодинического лечения боли, способ лечения невропатической боли
US20090170854A1 (en) New Use
CZ20014289A3 (cs) Nové pouľití sloučenin jako antibakteriálních činidel
RU2000113729A (ru) Гетероциклические соединения для ингибирования секреции желудочной кислоты, способы их получения и их фармацевтические компоозиции
CA2440037A1 (en) Benzimidazole derivatives for modulating the rage receptor
SK280283B6 (sk) Farmaceutický prostriedok na liečenie žalúdočných
CN100376245C (zh) 结合有泰妥拉唑与消炎剂的药物组合物
CN1327844C (zh) 包含双膦酸类化合物和hmg－coa还原酶抑制剂的组合疗法
BG66282B1 (bg) Използване на алендронат за лечение на остеопороза
JP2024169669A (ja) 腔内適用による結直腸がんの細菌プロモーターを排除するための組成物
RU2004103475A (ru) Производные арил-или гетероарилазолилкарбинолов для лечения недержания мочи
Terpos et al. Management of complications in multiple myeloma
CA2968135A1 (en) Combination therapy effective against microorganisms, including drug resistant microorganisms
US8623864B2 (en) Thioridazine and derivatives thereof for reversing anti-microbial drug-resistance
SE0201837D0 (sv) Chemical compounds
AU2002235080A1 (en) New use
NZ532282A (en) Pharmaceutical combination for use for the treatment of malignancies comprising a bisphosphonate, a COX-2 inhibitor and a taxol
JP2010523470A (ja) 抗癌化合物の投与方法
KR20040078118A (ko) 치환된 아크릴로일 디스타마이신 유도체 및 단백질 키나제(세린/트레오닌 키나제) 저해제를 포함하는 항종양 조합요법
GB2590341A (en) Storage stable somatostatin-dopamine chimeric compounds and salt forms thereof
RU2006123423A (ru) Фармацевтические применения бисфосфонатов
RU2009128186A (ru) Производные трициклических аминов в качестве ингибиторов тирозинкиназы
ATE441653T1 (de) Phosphorenthaltende verbindugnen mit antithrombitische wirkung
KR20050100671A (ko) 이미다조피리딘 함유 조합물, 및 위장관 염증성 질환 치료시의 이의 용도

Legal Events

Date Code Title Description
FC9A Refused patent application